ARCHIVES

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

Rogers Eyes Saccharin Ban

March 18, 1977

Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates

January 30, 1998

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000